Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsMYC and the art of microRNA maintenancemicroRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo.Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.Effects of connective tissue growth factor (CTGF) gene silencing on the radiosensitivity of glioblastomaCancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancersSix1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factorEmerging biomarkers in glioblastomaNext generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI.Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.Current progress for the use of miRNAs in glioblastoma treatment.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis.Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signalingCombinatorial ensemble miRNA target prediction of co-regulation networks with non-prediction dataRegulatory role of miR-18a to CCN2 by TGF-β1 signaling pathway in pulmonary injury induced by nano-SiO2.
P2860
Q26747273-9337A685-9564-4DF2-AB3F-D9C6D8CE52DFQ26825457-1558B49A-D6EE-4259-965C-996990635AF3Q30407637-96DB86C1-68DE-44A2-9B36-8E73643DC126Q33555058-75B0ACBD-8BDC-4A1A-B518-2D11418C19AEQ34049023-C28EE076-F3CC-43AD-8ED8-7693B0520A94Q34414941-5D232F7D-1278-47B0-8BD3-67AE86E92686Q34537690-699AA7C5-8B29-4CC5-B0DC-97D1E91799BBQ35519420-3CD14459-395D-4F0E-8A16-B2777CA70397Q35835280-E9681702-7104-469A-B63F-EE9106B285F1Q37226521-C7A07294-6245-4A7B-9F17-83ABED756265Q37602977-E1435AA6-CA9E-430C-8D0F-6526A4959213Q37696701-F423891F-A284-43A9-9C80-4543F2DEBCA5Q38102611-D15B6B60-A921-4765-AA77-AA92BC1E3057Q38189850-CAF721CA-5D34-441C-A163-ECB458618A91Q38258015-D2A3AB94-EC63-4D09-91BB-A57F5717ED2FQ38368664-41173D68-C055-495B-BF6A-5135E638B8E7Q38724559-8A5F1CF0-95DC-45E0-9857-2B1A1F3454A9Q41626796-4B35EBE4-C6F3-47AF-8D70-E45C2723E22FQ47412936-95FC26E3-0201-48B5-B920-BA4091F52351
P2860
Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@en
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@nl
type
label
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@en
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@nl
prefLabel
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@en
Targeting of TGFβ signature an ...... oved survival in glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Targeting of TGFβ signature an ...... roved survival in glioblastoma
@en
P2093
Andy J Minn
Jamie L Fox
Michael Dews
P2860
P304
P356
10.1261/RNA.036467.112
P407
P577
2012-12-18T00:00:00Z